<DOC>
	<DOCNO>NCT00146822</DOCNO>
	<brief_summary>The REFLEx Study evaluate ENDOTAK RELIANCE G defibrillation lead GORE ePTFE-covered coil good well comparative commercially available defibrillation lead respect electrical performance termination efficacy spontaneous tachyarrhythmic episode .</brief_summary>
	<brief_title>REFLEx Study ( ENDOTAK RELIANCE G Evaluation Handling Electrical Performance</brief_title>
	<detailed_description />
	<criteria>Patients meet current ICD CRTD indication Patients go implanted one aforementioned ICD CRTD device Patients go implanted activefixation , dualcoil , endocardial defibrillation lead compatible connector ( i.e. , ENDOTAK RELIANCE G studycomparative ICD lead ) Patients sign date Patient Informed Consent form prior device implant Patients remain clinical care enrol physician approved center Patients least 18 year old Patients preexist transvenous lead system completely explanted Patients hypersensitive single dose approximately 1.0 mg dexamethasone acetate Patients expect receive heart transplant duration study Patients whose estimated life expectancy le 12 month due medical condition Patients currently likely receive tricuspid valve prosthesis Patients likely openchest surgery next three month Patients currently enrol another investigational study would directly impact treatment outcome REFLEx study . Patients mentally incompetent sign Patient Informed Consent form comply study Patients pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>